A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy

2002-04-06

Additional Metadata
Keywords	Chemotherapy, Efficacy, Methotrexate, Renal cell carcinoma, Safety
Persistent URL	doi.org/10.1007/s00280-001-0417-z, hdl.handle.net/1765/74300
Journal	Cancer Chemotherapy and Pharmacology
Organisation	Department of Pathology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Vis, A., van der Gaast, A., van Rhijn, B., Catsburg, T., Schmidt, C., & Mickisch, G. H. J. (2002). A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy. Cancer Chemotherapy and Pharmacology, 49(4), 342–345. doi:10.1007/s00280-001-0417-z

Publication